A prospective, multi-center, single-arm, open phase Ib clinical study of safety, tolerability and preliminary efficacy of anlotinib combined with duvalizumab in patients with advanced gastric or colorectal cancer who have failed second-line treatment
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Interventions: experimental group:Anlotinib combined with Duvalizumab Primary outcome(s): DLT Study Design: Single arm
创建时间：
2020-11-15
